Pacific
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D7910
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 76 $63,150 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $63,150 Current and potential, with all options
- Last date to order 85% complete
- IDV ceiling <1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) SPE2DR25D7910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2026 and is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and the U.S. Naval Fleet.
The contract encompasses a broad range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The IDC serves as a primary vehicle for efficiently procuring these essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract was awarded on a single-award basis without any set-aside requirements, indicating open competition. This contract is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish multiple regional prime vendor contracts to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.
Task orders
Show 40 more
Latest 50 of 76 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D7910?
SPE2DR25D7910 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D7910 worth?
Orders under SPE2DR25D7910 have obligated $63,150. SPE2DR25D7910's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D7910?
76 orders have been placed under SPE2DR25D7910, the latest on May 18, 2026.
Who can order from contract SPE2DR25D7910?
SPE2DR25D7910 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D7910 competed?
The extent of competition for SPE2DR25D7910 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV